Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma
Michael Chiorazzi1, Lixin Rui, Yandan Yang
1Laboratory of Developmental Genetics, The Rockefeller University, New York, NY 10065, USA.
Abstract:
Cell death is a common metazoan cell fate, and its inactivation is central to human malignancy. In Caenorhabditis elegans, apoptotic cell death occurs via the activation of the caspase CED-3 following binding of the EGL-1/BH3-only protein to the antiapoptotic CED-9/BCL2 protein. Here we report a major alternative mechanism for caspase activation in vivo involving the F-box protein DRE-1. DRE-1 functions in parallel to EGL-1, requires CED-9 for activity, and binds to CED-9, suggesting that DRE-1 promotes apoptosis by inactivating CED-9. FBXO10, a human protein related to DRE-1, binds BCL2 and promotes its degradation, thereby initiating cell death. Moreover, some human diffuse large B-cell lymphomas have inactivating mutations in FBXO10 or express FBXO10 at low levels. Our results suggest that DRE-1/FBXO10 is a conserved regulator of apoptosis.
Insights
Researchers discovered a new cell death pathway in C. elegans involving DRE-1, which inactivates CED-9 to promote apoptosis. The related human protein FBXO10 also regulates cell death and is implicated in lymphomas.
Area of Science:
- Cell Biology
- Molecular Biology
- Genetics
Background:
- Apoptotic cell death is crucial in metazoans and its dysregulation is linked to cancer.
- In C. elegans, apoptosis is mediated by caspase CED-3 activation, triggered by EGL-1 binding to CED-9.
- Understanding alternative cell death pathways is vital for cancer research.
Purpose of the Study:
- To identify novel mechanisms regulating apoptosis in vivo.
- To investigate the role of F-box protein DRE-1 in programmed cell death.
- To explore the conserved function of DRE-1 and its human homolog, FBXO10, in cell death regulation.
Main Methods:
- Utilized Caenorhabditis elegans as a model organism.
- Investigated the interaction between DRE-1, CED-9, and CED-3.
- Analyzed the function of human FBXO10 in cell death and its association with diffuse large B-cell lymphomas.
Main Results:
- Identified DRE-1 as a key regulator of apoptosis acting in parallel to EGL-1.
- Demonstrated that DRE-1 requires CED-9 for its apoptotic activity and directly binds to CED-9.
- Showed that human FBXO10 binds BCL2, promotes its degradation, and initiates cell death.
- Found inactivating mutations or low expression of FBXO10 in some diffuse large B-cell lymphomas.
Conclusions:
- DRE-1 represents a significant alternative pathway for caspase activation and apoptosis induction in C. elegans.
- FBXO10, the human ortholog of DRE-1, is a conserved regulator of apoptosis.
- Dysregulation of the DRE-1/FBXO10 pathway may contribute to the development of certain cancers, such as diffuse large B-cell lymphoma.
More Related Videos
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Canonical Wnt Signaling Pathway
Cellular Injury V: Apoptosis and Autophagy
Caspases


